Dr. Sung Kwon
Claim this profileHoly Name Hospital
Studies Pancreatic Cancer
Studies Pancreatic Carcinoma
2 reported clinical trials
25 drugs studied
Area of expertise
1Pancreatic Cancer
Stage III
Stage IV
2Pancreatic Carcinoma
Affiliated Hospitals
Clinical Trials Sung Kwon is currently running
Perioperative Chemotherapy
for Pancreatic Cancer
This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs, such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery (perioperatively) may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).
Recruiting4 awards Phase 318 criteria
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting1 award Phase 217 criteria
More about Sung Kwon
Clinical Trial Related5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Sung Kwon has experience with
- Fluorouracil
- Oxaliplatin
- Irinotecan Hydrochloride
- Leucovorin Calcium
- Resection
- Binimetinib
Breakdown of trials Sung Kwon has run
Pancreatic Carcinoma
Fallopian Tube Cancer
Breast Cancer
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sung Kwon specialize in?
Sung Kwon focuses on Pancreatic Cancer and Pancreatic Carcinoma. In particular, much of their work with Pancreatic Cancer has involved Stage III patients, or patients who are Stage IV.
Is Sung Kwon currently recruiting for clinical trials?
Yes, Sung Kwon is currently recruiting for 2 clinical trials in Teaneck New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Sung Kwon has studied deeply?
Yes, Sung Kwon has studied treatments such as Fluorouracil, Oxaliplatin, Irinotecan Hydrochloride.
What is the best way to schedule an appointment with Sung Kwon?
Apply for one of the trials that Sung Kwon is conducting.
What is the office address of Sung Kwon?
The office of Sung Kwon is located at: Holy Name Hospital, Teaneck, New Jersey 07666 United States. This is the address for their practice at the Holy Name Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.